-
-
-
This article reports findings of a task force set up by the Society of Critical Care Medicine in 2008 to study intensivist workforce issues in the face of the ongoing increase in ICU beds and numbers of critically ill patients.
-
In this issue: New recommendations for HPV vaccine; guidelines for treatment of essential tremor; updates on smoking cessation drugs; and FDA actions.
-
Sickle cell disease celebrated its 100th anniversary last year, prompting consideration of what has transpired for those with the disease since its description by Dr. James Herrick in 1910.
-
This paper presents the findings from a systematic review and meta-analysis of available randomized, controlled trials (RCTs) published through July 2011 and retrieved from a variety of electronic search databases worldwide.
-
When I was a medicine resident 40 years ago just as the first ICUs were being introduced, treatment for life-threatening bacterial infections consisted of antibiotics, control or removal of the primary source, intravenous fluids, and vasopressors.
-
-
Xigris® (drotrecogin alfa [activated]), a recombinant form of human activated protein C, received FDA approval in November 2001 for the reduction of mortality in adult patients with severe sepsis with a high risk of death.
-
Congenital toxoplasmosis occurs exclusively in infants born to mothers who acquire primary infection during their pregnancy. Unfortunately, many of these infections occur without clinical signs or symptoms, and the mothers go untreated.
